Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 3
2004 15
2005 3
2006 5
2007 5
2008 4
2009 4
2010 6
2011 4
2012 11
2013 5
2014 7
2015 5
2016 9
2017 3
2018 5
2019 6
2020 5
2021 3
2022 5
2023 2
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

109 results

Results by year

Filters applied: . Clear all
Page 1
Epigenetics in the perioperative period.
Lirk P, Fiegl H, Weber NC, Hollmann MW. Lirk P, et al. Among authors: fiegl h. Br J Pharmacol. 2015 Jun;172(11):2748-55. doi: 10.1111/bph.12865. Epub 2015 Apr 27. Br J Pharmacol. 2015. PMID: 25073649 Free PMC article. Review.
Ovarian cancer stem cells.
Zeimet AG, Reimer D, Sopper S, Boesch M, Martowicz A, Roessler J, Wiedemair AM, Rumpold H, Untergasser G, Concin N, Hofstetter G, Muller-Holzner E, Fiegl H, Marth C, Wolf D, Pesta M, Hatina J. Zeimet AG, et al. Among authors: fiegl h. Neoplasma. 2012;59(6):747-55. doi: 10.4149/neo_2012_094. Neoplasma. 2012. PMID: 22862176 Review.
DNA hypomethylation is prevalent even in low-grade breast cancers.
Jackson K, Yu MC, Arakawa K, Fiala E, Youn B, Fiegl H, Müller-Holzner E, Widschwendter M, Ehrlich M. Jackson K, et al. Among authors: fiegl h. Cancer Biol Ther. 2004 Dec;3(12):1225-31. doi: 10.4161/cbt.3.12.1222. Epub 2004 Dec 9. Cancer Biol Ther. 2004. PMID: 15539937 Review.
Epigenetic stem cell signature in cancer.
Widschwendter M, Fiegl H, Egle D, Mueller-Holzner E, Spizzo G, Marth C, Weisenberger DJ, Campan M, Young J, Jacobs I, Laird PW. Widschwendter M, et al. Among authors: fiegl h. Nat Genet. 2007 Feb;39(2):157-8. doi: 10.1038/ng1941. Epub 2006 Dec 31. Nat Genet. 2007. PMID: 17200673
Dubious effects of methadone as an "anticancer" drug on ovarian cancer cell-lines and patient-derived tumor-spheroids.
Fiegl H, Hagenbuchner J, Kyvelidou C, Seeber B, Sopper S, Tsibulak I, Wieser V, Reiser E, Roessler J, Huhtinen K, Carpén O, Parson W, Sprung S, Marth C, Ausserlechner MJ, Zeimet AG. Fiegl H, et al. Gynecol Oncol. 2022 Apr;165(1):129-136. doi: 10.1016/j.ygyno.2022.01.008. Epub 2022 Jan 13. Gynecol Oncol. 2022. PMID: 35033381 Free article.
Clinical Impact of RANK Signalling in Ovarian Cancer.
Wieser V, Sprung S, Tsibulak I, Haybaeck J, Hackl H, Fiegl H, Marth C, Zeimet AG. Wieser V, et al. Among authors: fiegl h. Cancers (Basel). 2019 Jun 8;11(6):791. doi: 10.3390/cancers11060791. Cancers (Basel). 2019. PMID: 31181781 Free PMC article.
Integrated analysis of cervical squamous cell carcinoma cohorts from three continents reveals conserved subtypes of prognostic significance.
Chakravarthy A, Reddin I, Henderson S, Dong C, Kirkwood N, Jeyakumar M, Rodriguez DR, Martinez NG, McDermott J, Su X, Egawa N, Fjeldbo CS, Skingen VE, Lyng H, Halle MK, Krakstad C, Soleiman A, Sprung S, Lechner M, Ellis PJI, Wass M, Michaelis M, Fiegl H, Salvesen H, Thomas GJ, Doorbar J, Chester K, Feber A, Fenton TR. Chakravarthy A, et al. Among authors: fiegl h. Nat Commun. 2022 Oct 7;13(1):5818. doi: 10.1038/s41467-022-33544-x. Nat Commun. 2022. PMID: 36207323 Free PMC article.
109 results